Developer docs
API playgroundTry for free, no card

Search company profiles

Keraplast

Full company profile

uuid0004gqo

Namestring
Keraplast
Legal namestring
Keraplast Manufacturing
Websiteurl
keraplast.com
Company typeenum
Private
Founded yearint
1996
Descriptiontext

Keraplast is a privately held B2B biotechnology company, headquartered and manufacturing in Christchurch, New Zealand, that develops and supplies functional keratin protein ingredients to brand owners in personal care, nutraceutical, and wound care markets across 22 countries. The company operates as a wholly owned subsidiary of the US-based Keraplast Technologies LLC and traces its origin to a 1996 US founding by Dr Robert Allen Smith and a 2001 New Zealand research initiative by Keratec, which merged in the early 2000s into a single entity with 130+ individual patents across 36 patent families (28 listed on the company site).

Keraplast's core technology is the Functional Keratin® platform — a proprietary extraction process that recovers soluble, bioactive keratin proteins and peptides from regeneratively farmed New Zealand sheep's wool while preserving cystine content and controlling molecular weight, unlike conventional hydrolysis that destroys bioactivity. The platform yields three distinct keratin types (intermediate filament proteins, oxidised keratin 91% homologous to human hair, and hydrolysed keratin) that feed a portfolio of branded ingredients: ingestible keraGEN-IV® for hair/skin/nail nutraceuticals; topical actives Cynergy TK™, FK Repair Ultra™, FK Scalp™, FK Restore™, FK Protect Plus™, and CoreTX-pep™ for personal-care formulations; and Replicine™-based wound-care products Keramatrix®, Keragel®, and Kerox® for advanced wound management.

The business model is B2B ingredient supply: Keraplast manufactures proprietary keratin ingredients and sells them, typically under branded ingredient names with documented clinical claims (e.g., 43.1% reduction in hair fall, 82% decrease in breakage of coloured hair, 25% wrinkle reduction), to consumer-brand manufacturers and global ingredient distributors including Croda International, AIDP Inc, and IFF Health, with regional channel coverage via CDL Union in Asia. In 2025 the company added an exclusive MedTech manufacturing arrangement with BioWound Solutions (US) for wound-care products, extended its raw-material supply via a five-year, 400-tonne Wools of New Zealand contract, and launched a suite of new keraGEN-IV nutraceutical SKUs globally. Pricing is quote-based and not publicly disclosed.

Short descriptiontext

Keraplast is a New Zealand-based B2B biotechnology company that manufactures functional keratin protein ingredients from regeneratively farmed sheep's wool and supplies them to brand owners in personal care, nutraceutical, and wound care markets across 22 countries.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersChristchurch, New Zealand
HQ citystring
Christchurch
HQ countrystring
New Zealand
HQ regionstring
Oceania
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
functional keratin ingredients, bioactive protein extraction, nutraceutical ingredient supply, personal care ingredients, wound care biomaterials
Industry3 codes
PRIMARYAFAJAHAL
Specialty & Novel Proteins (Single-Cell Protein, Cell-Cultured/Animal-Free Proteins)
Agriculture & Food Production/Food Ingredients & Additives/Proteins & Protein Ingredients (Plant/Animal Proteins, Protein Isolates/Concentrates)
SECONDARYCRADAOAJ
Proteins & Functional Nutrition Ingredients (Plant/Animal Proteins, Collagen, Amino Acids)
SECONDARYHLAMAHAH
Nutraceuticals & Functional Ingredients for Animal Diets (Probiotics, Omega-3, Joint, GI)
Healthcare & Life Sciences/Veterinary & Animal Health/Animal Nutrition & Therapeutic Diets
Product category
Functional Keratin Ingredients
Social media profiles1 record
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model2 records
1B2B Ingredient Supply
TypeOne Time License
Description

Keraplast manufactures and sells branded functional keratin ingredients (keraGEN-IV, Cynergy TK, FK Repair Ultra, FK Scalp, FK Restore, FK Protect Plus, CoreTX-pep) to personal care and nutraceutical manufacturers and distributors in global markets including Europe, China, UK, and USA.

keraplast.com
2Medical Device Manufacturing
TypeLicensing Royalties
Description

Exclusive manufacturing agreement with BioWound Solutions to manufacture keratin-based wound care products (Keramatrix®, Keragel®, Kerox®) for the US market. Signals entry into MedTech business with production of medical devices.

keraplast.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Operations, Personnel, Technology or R&D, Infrastructure, Marketing or Sales
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 10 records shown
1keraGEN-IV
Description

Inner Beauty (Ingestible) - Bioactive keratin ingredient for supporting keratin metabolism, promoting hair, skin, and nail health through oral supplementation.

keraplast.com
+9 more records
Core offering1 text field

Keraplast manufactures and supplies branded, soluble, bioactive keratin protein and peptide ingredients recovered from regeneratively farmed New Zealand sheep's wool. Its Functional Keratin® platform produces three keratin types (IFP, oxidised, hydrolysed) serving personal care (hair and skin), nutraceutical (ingestible beauty/wellness), wound care (MedTech), and pet wellness brand customers through B2B ingredient supply and an exclusive US wound-care manufacturing partnership with BioWound Solutions.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 11 values shown
  • 43.1% reduction in hair fall demonstrated in gold standard clinical trial
+10 more records
Product overview1 text field

Keraplast is a B2B biotechnology company that manufactures and supplies functional keratin ingredients to global health, nutrition, and personal care companies. The portfolio consists of three main categories: (1) Nutraceutical ingredients including keraGEN-IV® for ingestible beauty supplements supporting hair, skin, and nail health from within; (2) Personal Care ingredients including Cynergy TK™, FK Repair Ultra™, FK Scalp™, FK Restore™, FK Protect Plus™, and CoreTX-pep™ for topical hair and skincare formulations; and (3) MedTech products including Keramatrix®, Keragel®, and Kerox® for advanced wound care applications. All products are based on bioactive keratin proteins recovered from regeneratively farmed New Zealand sheep's wool using proprietary extraction processes that preserve protein functionality and bioactivity.

Product and service10 records
1keraGEN-IV®
CategoryNutraceutical Ingredient
Description

Ingestible functional keratin ingredient supplying keratin-derived peptides that support keratin metabolism for normal formation and renewal of hair, skin, and nails. Clinically validated for hair anchoring (43.1% reduction in hair fall) and collagen IV/VII production, sold B2B to nutraceutical and pet wellness brands.

2Cynergy TK™
CategoryPersonal Care Ingredient
Description

Topical bioactive ingredient featuring keratin peptides and intermediate filament proteins for skincare. Delivers 160% increase in cell proliferation, 27% improvement in skin smoothness, 25% wrinkle reduction, and 70% reduction in PGE2 (inflammation marker); sold B2B to personal care brands.

3FK Repair Ultra™
CategoryPersonal Care Ingredient
Description

Salon-quality topical ingredient of oxidised keratin 91% homologous to human hair that repairs damaged hair. Decreases breakage of colored hair by 82%, reduces color fade by 55%, and increases tensile strength of colored hair by 26%; sold B2B.

4FK Scalp™
CategoryPersonal Care Ingredient
Description

Topical scalp-care ingredient formulated to improve scalp health via pollution and UV protection, and to promote follicle anchoring. Demonstrated up to 160% faster skin cell proliferation and up to 70% reduction in PGE2 inflammatory response; sold B2B.

5FK Restore™
CategoryPersonal Care Ingredient
Description

Proprietary blend of keratin proteins for damaged hair repair that penetrates the cortex to nourish, strengthen, and reduce breakage. Provides 80% reduction in breakage and 52% stronger chemically treated hair; sold B2B.

6FK Protect Plus™
CategoryPersonal Care Ingredient
Description

Topical film-forming keratin protein that creates a natural protective layer against environmental aggressors such as pollution and UV. Seals moisture, smooths fiber surface, and delivers antioxidant potential; sold B2B.

7CoreTX-pep™
CategoryPersonal Care Ingredient
Description

Topical ingredient containing novel wool cortex peptides that permanently bind to damaged hair and nails to increase integrity. Provides 33% improvement in extension and flexibility in UV-exposed hair and improved nail and skin condition; sold B2B.

8Keramatrix®
CategoryMedTech Wound Care Product
Description

Advanced keratin-based wound care product that promotes cellular regeneration and natural wound closure while reducing scarring. Manufactured exclusively by Keraplast under its Replicine™ keratin technology for BioWound Solutions for the US wound care market.

9Keragel®
CategoryMedTech Wound Care Product
Description

Advanced keratin-based wound care product using proprietary Replicine™ keratin technology for cellular regeneration and natural wound closure. Manufactured by Keraplast under an exclusive US agreement with BioWound Solutions.

10Kerox®
CategoryMedTech Wound Care Product
Description

Advanced keratin-based wound care product manufactured by Keraplast under its exclusive US manufacturing agreement with BioWound Solutions for the wound care market.

Scale indicator9 records

Each record includes

Type, Value, Description, Source

Partnership11 partners
Strategic tierCoreTypeOEM/ Whitelabel/ Licensing PartnerAnnounced on2025-10-02
Description

Exclusive manufacturing agreement for BioWound's advanced keratin-based wound care products (Keramatrix®, Keragel®, Kerox®) for US market. BioWound Solutions is a leader in innovative wound management based in Las Vegas. Partnership leverages Keraplast's Replicine™ keratin technology to redefine standards of care for chronic wound patients.

2Dog Years
Strategic tierEmergingTypeOEM/ Whitelabel/ Licensing PartnerAnnounced on2025-04-24
Description

Dog Years launched 'Skin & Coat' - first petcare supplement to feature keraGEN-IV for nourishing skin and fur from within. Represents Keraplast's entry into pet wellness market leveraging their innovative keratin technology.

keraplast.com
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-04-18
Description

UniAsia launched See Young Pro premium haircare line in Beijing, formulated with Keraplast's functional keratin ingredients for advanced hair restoration and protection. Partnership exemplifies synergy between innovative ingredient technology and premium haircare formulation.

4CDL Union
Strategic tierKeyTypeChannel Partner/ Reseller/ DistributorAnnounced on2025-04-18
Description

CDL Union is a key Asian distribution partner for Keraplast. Discussions focused on strengthening collaboration to ensure continued success of distributing Keraplast's high-quality keratin ingredients across key Asian markets including China.

keraplast.com
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-02-10
Description

Five-year super-premium wool contract (2025-2026: $6.88/kg clean, ~40% premium over market) covering 400 tonnes of wool from ~30 regeneratively certified NZ growers. WONZ CEO John McWhirter sees it as a vote of confidence in NZ wool's future, linking growers to high-value end uses. Strengthens supply chain traceability and sustainability credentials.

Strategic tierCoreTypeOEM/ Whitelabel/ Licensing Partner
Description

Keraplast is the keratin supplier to Nutrafol, supplying keraGEN-IV functional keratin for their hair supplement products. Nutrafol targets Asia for next phase of hair supplement sector growth.

Strategic tierKeyTypeStrategic or Co-development Partner
Description

Strong global partnership with Croda International, a major life sciences and consumer care company. Through this partnership, Keraplast's functional keratin ingredients have achieved global reach enhancing wellbeing of millions of people.

Strategic tierKeyTypeStrategic or Co-development Partner
Description

Strong partnership with AIDP Inc for distribution and commercialization of keratin ingredients. AIDP is a leading provider of functional ingredients for nutrition and health.

Strategic tierKeyTypeStrategic or Co-development Partner
Description

Strong partnership with IFF Health (International Flavors & Fragrances) for global reach of life-changing keratin ingredients in health and wellness applications.

Strategic tierSupportingTypeStrategic or Co-development Partner
Description

Research collaboration with AgResearch, New Zealand's largest agricultural research organization. Supports fundamental and applied keratin science research programs.

Strategic tierSupportingTypeStrategic or Co-development Partner
Description

Partnership with New Zealand's Innovation Agency for research and development support, helping bring keratin innovations from concept through to commercial application.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
1Mibelle Biochemistry
TypeDirect peer
Description

Swiss developer of bioactive cosmetic ingredients (peptides, proteins, plant-cell actives) sold B2B to personal care formulators globally. Closely comparable to Keraplast's topical personal care ingredient range (Cynergy TK, FK Repair Ultra, etc.) in customer base and application focus.

TypeBroad incumbent
Description

Global specialty ingredients major with personal care, life sciences, and nutraceutical divisions. Already a Keraplast distribution partner; comparable as a broad incumbent whose portfolio overlaps Keraplast's protein/keratin ingredients at scale.

TypeBroad incumbent
Description

Specialty chemicals/ingredients group with personal care and nutraceutical protein/peptide offerings. Comparable as a broad incumbent ingredient supplier competing for the same B2B formulation slots.

4BioCell Collagen
TypeDirect peer
Description

Supplies branded collagen/hyaluronic-acid ingredients (BioCell Collagen) to nutraceutical brands for skin, joint, and beauty-from-within supplements. Highly comparable to Keraplast's keraGEN-IV as a science-backed, branded protein ingredient sold to supplement manufacturers.

5Lonza Capsules & Health Ingredients
TypeBroad incumbent
Description

Global manufacturer of nutraceutical and personal care ingredients including proteins and peptides. Comparable as a broad incumbent serving overlapping personal-care and supplement customers with scaled manufacturing.

TypeBroad incumbent
Description

Global ingredients giant with health, biosciences, and personal care segments. Already a Keraplast distribution partner; comparable as a large incumbent whose protein/functional-ingredient portfolio overlaps Keraplast's targeted offering.

TypeBroad incumbent
Description

Global medical-device incumbent in advanced wound care (chronic wounds, ostomy, continence). Comparable as a broad incumbent competing in the same wound-care end market Keraplast is entering via the BioWound Solutions manufacturing deal.

TypeDirect peer
Description

Commercialises regenerative medicine and bioactive wound-care products (e.g., Apligraf, Dermagraft) using biomaterial technologies. Comparable to Keraplast's Replicine™ wound-care platform as a biomaterials-based MedTech player in chronic wound healing.

TypeDirect peer
Description

Supplies patented, clinically validated branded nutraceutical ingredients (Pycnogenol) to supplement manufacturers worldwide. Closely analogous business model to Keraplast's keraGEN-IV — a single hero IP-protected ingredient licensed into many supplement brands.

TypeDirect peer
Description

Geltor produces animal-free, fermentation-derived proteins (collagen, elastin, keratin-like) for personal care and nutraceutical brands. Directly comparable as a specialty protein ingredient supplier selling B2B to cosmetics and supplement manufacturers, but uses precision fermentation rather than wool extraction.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers8 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles9 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds7 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Keraplast

Functional Keratin Ingredientskeraplast.com

Keraplast is a New Zealand-based B2B biotechnology company that manufactures functional keratin protein ingredients from regeneratively farmed sheep's wool and supplies them to brand owners in personal care, nutraceutical, and wound care markets across 22 countries.

What Keraplast does

Keraplast is a privately held B2B biotechnology company, headquartered and manufacturing in Christchurch, New Zealand, that develops and supplies functional keratin protein ingredients to brand owners in personal care, nutraceutical, and wound care markets across 22 countries. The company operates as a wholly owned subsidiary of the US-based Keraplast Technologies LLC and traces its origin to a 1996 US founding by Dr Robert Allen Smith and a 2001 New Zealand research initiative by Keratec, which merged in the early 2000s into a single entity with 130+ individual patents across 36 patent families (28 listed on the company site).

Keraplast's core technology is the Functional Keratin® platform — a proprietary extraction process that recovers soluble, bioactive keratin proteins and peptides from regeneratively farmed New Zealand sheep's wool while preserving cystine content and controlling molecular weight, unlike conventional hydrolysis that destroys bioactivity. The platform yields three distinct keratin types (intermediate filament proteins, oxidised keratin 91% homologous to human hair, and hydrolysed keratin) that feed a portfolio of branded ingredients: ingestible keraGEN-IV® for hair/skin/nail nutraceuticals; topical actives Cynergy TK™, FK Repair Ultra™, FK Scalp™, FK Restore™, FK Protect Plus™, and CoreTX-pep™ for personal-care formulations; and Replicine™-based wound-care products Keramatrix®, Keragel®, and Kerox® for advanced wound management.

The business model is B2B ingredient supply: Keraplast manufactures proprietary keratin ingredients and sells them, typically under branded ingredient names with documented clinical claims (e.g., 43.1% reduction in hair fall, 82% decrease in breakage of coloured hair, 25% wrinkle reduction), to consumer-brand manufacturers and global ingredient distributors including Croda International, AIDP Inc, and IFF Health, with regional channel coverage via CDL Union in Asia. In 2025 the company added an exclusive MedTech manufacturing arrangement with BioWound Solutions (US) for wound-care products, extended its raw-material supply via a five-year, 400-tonne Wools of New Zealand contract, and launched a suite of new keraGEN-IV nutraceutical SKUs globally. Pricing is quote-based and not publicly disclosed.

Keraplast firmographics

Firmographics
Name
Keraplast
Legal name
Keraplast Manufacturing
Website
https://keraplast.com
Company type
Private
Founded year
1996
Operating status
Operating
Headcount range
11–50 employees
Short description
Keraplast is a New Zealand-based B2B biotechnology company that manufactures functional keratin protein ingredients from regeneratively farmed sheep's wool and supplies them to brand owners in personal care, nutraceutical, and wound care markets across 22 countries.
Ownership category
akta.pro rank

Keraplast industry classification

Industry
Product category
Functional Keratin Ingredients
akta.pro industry
PRIMARYAFAJAHAL
Specialty & Novel Proteins (Single-Cell Protein, Cell-Cultured/Animal-Free Proteins)
Agriculture & Food Production/Food Ingredients & Additives/Proteins & Protein Ingredients (Plant/Animal Proteins, Protein Isolates/Concentrates)
SECONDARYCRADAOAJ
Proteins & Functional Nutrition Ingredients (Plant/Animal Proteins, Collagen, Amino Acids)
SECONDARYHLAMAHAH
Nutraceuticals & Functional Ingredients for Animal Diets (Probiotics, Omega-3, Joint, GI)
Healthcare & Life Sciences/Veterinary & Animal Health/Animal Nutrition & Therapeutic Diets

Keywords

  • Functional keratin ingredients
  • Bioactive protein extraction
  • Nutraceutical ingredient supply
  • Personal care ingredients
  • Wound care biomaterials

Where Keraplast is headquartered

Location

Headquarters

HQ city
Christchurch
HQ country
New Zealand
HQ region
Oceania

Offices2 records

Markets served

Keraplast business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Personnel, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

  1. B2B Ingredient Supply: Keraplast manufactures and sells branded functional keratin ingredients (keraGEN-IV, Cynergy TK, FK Repair Ultra, FK Scalp, FK Restore, FK Protect Plus, CoreTX-pep) to personal care and nutraceutical manufacturers and distributors in global markets including Europe, China, UK, and USA.
  2. Medical Device Manufacturing: Exclusive manufacturing agreement with BioWound Solutions to manufacture keratin-based wound care products (Keramatrix®, Keragel®, Kerox®) for the US market. Signals entry into MedTech business with production of medical devices.

Go-to-market motion3 records

Distribution channels3 records

Marketing channels7 records

Keraplast product offering

Product offering

Core offering

Keraplast manufactures and supplies branded, soluble, bioactive keratin protein and peptide ingredients recovered from regeneratively farmed New Zealand sheep's wool. Its Functional Keratin® platform produces three keratin types (IFP, oxidised, hydrolysed) serving personal care (hair and skin), nutraceutical (ingestible beauty/wellness), wound care (MedTech), and pet wellness brand customers through B2B ingredient supply and an exclusive US wound-care manufacturing partnership with BioWound Solutions.

Product overview

Keraplast is a B2B biotechnology company that manufactures and supplies functional keratin ingredients to global health, nutrition, and personal care companies. The portfolio consists of three main categories: (1) Nutraceutical ingredients including keraGEN-IV® for ingestible beauty supplements supporting hair, skin, and nail health from within; (2) Personal Care ingredients including Cynergy TK™, FK Repair Ultra™, FK Scalp™, FK Restore™, FK Protect Plus™, and CoreTX-pep™ for topical hair and skincare formulations; and (3) MedTech products including Keramatrix®, Keragel®, and Kerox® for advanced wound care applications. All products are based on bioactive keratin proteins recovered from regeneratively farmed New Zealand sheep's wool using proprietary extraction processes that preserve protein functionality and bioactivity.

Differentiator

Problem solved

Functional benefit

Brands

  • keraGEN-IV: Inner Beauty (Ingestible) - Bioactive keratin ingredient for supporting keratin metabolism, promoting hair, skin, and nail health through oral supplementation.
  • Cynergy TK
  • FK Repair Ultra
  • FK Scalp
  • FK Restore
  • FK Protect Plus
  • CoreTX-pep
  • Keramatrix
  • Keragel
  • KeragelT

Products and services

  • keraGEN-IV® Ingestible functional keratin ingredient supplying keratin-derived peptides that support keratin metabolism for normal formation and renewal of hair, skin, and nails. Clinically validated for hair anchoring (43.1% reduction in hair fall) and collagen IV/VII production, sold B2B to nutraceutical and pet wellness brands.
  • Cynergy TK™ Topical bioactive ingredient featuring keratin peptides and intermediate filament proteins for skincare. Delivers 160% increase in cell proliferation, 27% improvement in skin smoothness, 25% wrinkle reduction, and 70% reduction in PGE2 (inflammation marker); sold B2B to personal care brands.
  • FK Repair Ultra™ Salon-quality topical ingredient of oxidised keratin 91% homologous to human hair that repairs damaged hair. Decreases breakage of colored hair by 82%, reduces color fade by 55%, and increases tensile strength of colored hair by 26%; sold B2B.
  • FK Scalp™ Topical scalp-care ingredient formulated to improve scalp health via pollution and UV protection, and to promote follicle anchoring. Demonstrated up to 160% faster skin cell proliferation and up to 70% reduction in PGE2 inflammatory response; sold B2B.
  • FK Restore™ Proprietary blend of keratin proteins for damaged hair repair that penetrates the cortex to nourish, strengthen, and reduce breakage. Provides 80% reduction in breakage and 52% stronger chemically treated hair; sold B2B.
  • FK Protect Plus™ Topical film-forming keratin protein that creates a natural protective layer against environmental aggressors such as pollution and UV. Seals moisture, smooths fiber surface, and delivers antioxidant potential; sold B2B.
  • CoreTX-pep™ Topical ingredient containing novel wool cortex peptides that permanently bind to damaged hair and nails to increase integrity. Provides 33% improvement in extension and flexibility in UV-exposed hair and improved nail and skin condition; sold B2B.
  • Keramatrix® Advanced keratin-based wound care product that promotes cellular regeneration and natural wound closure while reducing scarring. Manufactured exclusively by Keraplast under its Replicine™ keratin technology for BioWound Solutions for the US wound care market.
  • Keragel® Advanced keratin-based wound care product using proprietary Replicine™ keratin technology for cellular regeneration and natural wound closure. Manufactured by Keraplast under an exclusive US agreement with BioWound Solutions.
  • Kerox® Advanced keratin-based wound care product manufactured by Keraplast under its exclusive US manufacturing agreement with BioWound Solutions for the wound care market.

Quantifiable outcome

  • 43.1% reduction in hair fall demonstrated in gold standard clinical trial
  • +10 more outcomes

Companies that use Keraplast

Customer profile

Named customers8 records

Segments4 records

Ideal customer profiles4 records

Keraplast technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

Keraplast partnerships and signals

Strategic signal

Partnerships

Eleven partnerships are on record, tiered core, emerging, key and supporting.

  • BioWound SolutionscoreOEM/ Whitelabel/ Licensing Partner · 2 October 2025Exclusive manufacturing agreement for BioWound's advanced keratin-based wound care products (Keramatrix®, Keragel®, Kerox®) for US market. BioWound Solutions is a leader in innovative wound management based in Las Vegas. Partnership leverages Keraplast's Replicine™ keratin technology to redefine standards of care for chronic wound patients.
  • Dog YearsemergingOEM/ Whitelabel/ Licensing Partner · 24 April 2025Dog Years launched 'Skin & Coat' - first petcare supplement to feature keraGEN-IV for nourishing skin and fur from within. Represents Keraplast's entry into pet wellness market leveraging their innovative keratin technology.
  • UniAsiacoreStrategic or Co-development Partner · 18 April 2025UniAsia launched See Young Pro premium haircare line in Beijing, formulated with Keraplast's functional keratin ingredients for advanced hair restoration and protection. Partnership exemplifies synergy between innovative ingredient technology and premium haircare formulation.
  • CDL UnionkeyChannel Partner/ Reseller/ Distributor · 18 April 2025CDL Union is a key Asian distribution partner for Keraplast. Discussions focused on strengthening collaboration to ensure continued success of distributing Keraplast's high-quality keratin ingredients across key Asian markets including China.
  • Wools of New ZealandcoreStrategic or Co-development Partner · 10 February 2025Five-year super-premium wool contract (2025-2026: $6.88/kg clean, ~40% premium over market) covering 400 tonnes of wool from ~30 regeneratively certified NZ growers. WONZ CEO John McWhirter sees it as a vote of confidence in NZ wool's future, linking growers to high-value end uses. Strengthens supply chain traceability and sustainability credentials.
  • NutrafolcoreOEM/ Whitelabel/ Licensing PartnerKeraplast is the keratin supplier to Nutrafol, supplying keraGEN-IV functional keratin for their hair supplement products. Nutrafol targets Asia for next phase of hair supplement sector growth.
  • Croda InternationalkeyStrategic or Co-development PartnerStrong global partnership with Croda International, a major life sciences and consumer care company. Through this partnership, Keraplast's functional keratin ingredients have achieved global reach enhancing wellbeing of millions of people.
  • AIDP InckeyStrategic or Co-development PartnerStrong partnership with AIDP Inc for distribution and commercialization of keratin ingredients. AIDP is a leading provider of functional ingredients for nutrition and health.
  • IFF HealthkeyStrategic or Co-development PartnerStrong partnership with IFF Health (International Flavors & Fragrances) for global reach of life-changing keratin ingredients in health and wellness applications.
  • AgResearchsupportingStrategic or Co-development PartnerResearch collaboration with AgResearch, New Zealand's largest agricultural research organization. Supports fundamental and applied keratin science research programs.
  • Callaghan InnovationsupportingStrategic or Co-development PartnerPartnership with New Zealand's Innovation Agency for research and development support, helping bring keratin innovations from concept through to commercial application.

Scale indicators9 records

Recent moves6 records

Expansion highlights6 records

Keraplast competitors and assessment

Company assessment

Direct peers

  • Mibelle Biochemistry: Swiss developer of bioactive cosmetic ingredients (peptides, proteins, plant-cell actives) sold B2B to personal care formulators globally. Closely comparable to Keraplast's topical personal care ingredient range (Cynergy TK, FK Repair Ultra, etc.) in customer base and application focus.
  • BioCell Collagen: Supplies branded collagen/hyaluronic-acid ingredients (BioCell Collagen) to nutraceutical brands for skin, joint, and beauty-from-within supplements. Highly comparable to Keraplast's keraGEN-IV as a science-backed, branded protein ingredient sold to supplement manufacturers.
  • Organogenesis: Commercialises regenerative medicine and bioactive wound-care products (e.g., Apligraf, Dermagraft) using biomaterial technologies. Comparable to Keraplast's Replicine™ wound-care platform as a biomaterials-based MedTech player in chronic wound healing.
  • Horphag Research: Supplies patented, clinically validated branded nutraceutical ingredients (Pycnogenol) to supplement manufacturers worldwide. Closely analogous business model to Keraplast's keraGEN-IV — a single hero IP-protected ingredient licensed into many supplement brands.
  • Geltor: Geltor produces animal-free, fermentation-derived proteins (collagen, elastin, keratin-like) for personal care and nutraceutical brands. Directly comparable as a specialty protein ingredient supplier selling B2B to cosmetics and supplement manufacturers, but uses precision fermentation rather than wool extraction.

Broad incumbents

  • Croda International: Global specialty ingredients major with personal care, life sciences, and nutraceutical divisions. Already a Keraplast distribution partner; comparable as a broad incumbent whose portfolio overlaps Keraplast's protein/keratin ingredients at scale.
  • Lubrizol Life Science (Beauty / Nutraceutical): Specialty chemicals/ingredients group with personal care and nutraceutical protein/peptide offerings. Comparable as a broad incumbent ingredient supplier competing for the same B2B formulation slots.
  • Lonza Capsules & Health Ingredients: Global manufacturer of nutraceutical and personal care ingredients including proteins and peptides. Comparable as a broad incumbent serving overlapping personal-care and supplement customers with scaled manufacturing.
  • IFF Health (International Flavors & Fragrances): Global ingredients giant with health, biosciences, and personal care segments. Already a Keraplast distribution partner; comparable as a large incumbent whose protein/functional-ingredient portfolio overlaps Keraplast's targeted offering.
  • ConvaTec: Global medical-device incumbent in advanced wound care (chronic wounds, ostomy, continence). Comparable as a broad incumbent competing in the same wound-care end market Keraplast is entering via the BioWound Solutions manufacturing deal.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

Keraplast social profiles

Digital presence

Keraplast compliance and trust

Trust signal

Compliance4 records

Keraplast financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Keraplast leadership team

Management profile

Number of profiles

Profiles9 records

Keraplast funding detail

Funding detail

Funding overview

Funding rounds7 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Keraplast M&A and investment

M&A and investment

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Keraplast

What does Keraplast do?

Keraplast manufactures and supplies branded, soluble, bioactive keratin protein and peptide ingredients recovered from regeneratively farmed New Zealand sheep's wool. Its Functional Keratin® platform produces three keratin types (IFP, oxidised, hydrolysed) serving personal care (hair and skin), nutraceutical (ingestible beauty/wellness), wound care (MedTech), and pet wellness brand customers through B2B ingredient supply and an exclusive US wound-care manufacturing partnership with BioWound Solutions.

Is Keraplast a public or private company?

Keraplast is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Keraplast founded?

Keraplast was founded in 1996. It employs 11 to 50 people.

Where is Keraplast based?

Keraplast is headquartered in Christchurch, New Zealand, in the Oceania region.

How does Keraplast make money?

Two revenue lines are on record. B2B Ingredient Supply is the primary driver. The others are medical Device Manufacturing.

Who are Keraplast's main competitors?

Direct peers on record are Mibelle Biochemistry, BioCell Collagen, Organogenesis, Horphag Research and Geltor. Broad incumbents are Croda International, Lubrizol Life Science (Beauty / Nutraceutical), Lonza Capsules & Health Ingredients, IFF Health (International Flavors & Fragrances) and ConvaTec.

Does Keraplast have an API?

No public API is recorded for Keraplast.

What industry is Keraplast in?

Keraplast's product category is Functional Keratin Ingredients. Its primary akta.pro industry code is AFAJAHAL, Specialty & Novel Proteins (Single-Cell Protein, Cell-Cultured/Animal-Free Proteins), with a secondary code of CRADAOAJ, Proteins & Functional Nutrition Ingredients (Plant/Animal Proteins, Collagen, Amino Acids).

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
EIN PresswireKeraplast Appoints Tony Rayner as General Manager – Nutraceuticals & Personal CareKeraplast appointed Tony Rayner as General Manager of its Nutraceuticals & Personal Care business. He brings over two decades of commercial leadership experience, including roles at Westland Milk Products, Asahi New Zealand, and Heinz Wattie's. He will lead commercial strategy and performance, working with the executive team to drive growth.Market ScoopKeratin Manufacturers Boost Biotechnology and DevelopmentThe keratin market is projected to reach USD 3,096.9 million by 2034, driven by demand in personal care, cosmetics, biomedical, and protein-based technologies, with Asia Pacific leading. Key companies like Hefei TNJ Chemical Industry Co., Ltd., Rejuvenol, and Keraplast are actively involved in manufacturing and innovating keratin ingredients.GlobeNewswireReplicine Functional Keratin wound care now available for US military healthcareKeraplast Technologies listed its Replicine Functional Keratin wound care products on the Federal Supply Schedule, making them available to VA facilities and active military organizations through Marathon Medical. The products include keragel, keramatrix, and kerasorb, and are intended for chronic and acute wounds.GlobeNewswireSaving Rhinos: ethical alternative to rhino horn introduced by Rhinoceros Horn LLC on Wildlife Conservation Day.Rhinoceros Horn LLC announced plans to fund an ethical alternative to rhino horn via IndieGoGo, aiming to reduce poaching incentives. The company will market a keratin protein powder biologically identical to rhino horn, produced sustainably with Keraplast Technologies. The initiative targets rhinos in India and South Africa.GlobeNewswireKeraplast discovers new exfoliant technologyKeraplast Technologies announced a new exfoliant technology using Replicine™ Functional Keratin particles to gently remove dead skin cells. The particles are designed to avoid irritation, unlike conventional exfoliants, and are available in the Retrospect Microdermabrasion Cream. The company states this is the first in-class technology.GlobeNewswireKeraplast launches new skin care system based on Replicine(tm) Functional Keratin(r) advanced wound care technologyKeraplast Technologies launched Keras, a skin care system for dermatologists and clinics, using Replicine Functional Keratin wound care technology. The system includes products like Intensive Serum and Microdermabrasion Cream to reduce downtime and improve cosmetic outcomes after skin treatments. The company states the technology is FDA and CE marked.GlobeNewswireWorld Leader in Keratin Technology to Launch State-Of-The-Art Luxury Skin Care LineKeraplast Technologies launched the Retrospect luxury skin care line at the Cosmoprof expo in Las Vegas on July 22-24, 2012. The eight-product system retails between $35 and $90, using Replicine™ Functional Keratin technology with over 170 patents.GlobeNewswireReplicine(TM) Functional Keratin(R) Enhances Skin Cell Growth and Expression of Collagen 4 and 7Keraplast Technologies announced findings from a peer-reviewed study showing wool-derived keratin stimulates human keratinocyte migration and expression of collagen types IV and VII. The research suggests the product may strengthen the dermal-epidermal junction, potentially benefiting patients with Epidermolysis Bullosa and reducing wrinkles.